BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 25650661)

  • 1. Farnesoid X receptor associates with β-catenin and inhibits its activity in hepatocellular carcinoma.
    Liu X; Zhang X; Ji L; Gu J; Zhou M; Chen S
    Oncotarget; 2015 Feb; 6(6):4226-38. PubMed ID: 25650661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased activation of the Wnt/β-catenin pathway in spontaneous hepatocellular carcinoma observed in farnesoid X receptor knockout mice.
    Wolfe A; Thomas A; Edwards G; Jaseja R; Guo GL; Apte U
    J Pharmacol Exp Ther; 2011 Jul; 338(1):12-21. PubMed ID: 21430080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NLRC5 regulates cell proliferation, migration and invasion in hepatocellular carcinoma by targeting the Wnt/β-catenin signaling pathway.
    Peng YY; He YH; Chen C; Xu T; Li L; Ni MM; Meng XM; Huang C; Li J
    Cancer Lett; 2016 Jun; 376(1):10-21. PubMed ID: 26975630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of miR-432 activates Wnt/β-catenin signaling and promotes human hepatocellular carcinoma proliferation.
    Jiang N; Chen WJ; Zhang JW; Xu C; Zeng XC; Zhang T; Li Y; Wang GY
    Oncotarget; 2015 Apr; 6(10):7866-79. PubMed ID: 25797263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells.
    Ma L; Wang X; Jia T; Wei W; Chua MS; So S
    Oncotarget; 2015 Sep; 6(28):25390-401. PubMed ID: 26246473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small molecule antagonists of Tcf4/beta-catenin complex inhibit the growth of HCC cells in vitro and in vivo.
    Wei W; Chua MS; Grepper S; So S
    Int J Cancer; 2010 May; 126(10):2426-36. PubMed ID: 19662654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dickkopf 4 (DKK4) acts on Wnt/β-catenin pathway by influencing β-catenin in hepatocellular carcinoma.
    Fatima S; Lee NP; Tsang FH; Kolligs FT; Ng IO; Poon RT; Fan ST; Luk JM
    Oncogene; 2012 Sep; 31(38):4233-44. PubMed ID: 22249261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ubiquitin-like protein FAT10 promotes the invasion and metastasis of hepatocellular carcinoma by modifying β-catenin degradation.
    Yuan R; Wang K; Hu J; Yan C; Li M; Yu X; Liu X; Lei J; Guo W; Wu L; Hong K; Shao J
    Cancer Res; 2014 Sep; 74(18):5287-300. PubMed ID: 25056121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of human farnesoid X receptor by miR-421 promotes proliferation and migration of hepatocellular carcinoma cells.
    Zhang Y; Gong W; Dai S; Huang G; Shen X; Gao M; Xu Z; Zeng Y; He F
    Mol Cancer Res; 2012 Apr; 10(4):516-22. PubMed ID: 22446874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CUL4B activates Wnt/β-catenin signalling in hepatocellular carcinoma by repressing Wnt antagonists.
    Yuan J; Han B; Hu H; Qian Y; Liu Z; Wei Z; Liang X; Jiang B; Shao C; Gong Y
    J Pathol; 2015 Apr; 235(5):784-95. PubMed ID: 25430888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-153 promotes Wnt/β-catenin activation in hepatocellular carcinoma through suppression of WWOX.
    Hua HW; Jiang F; Huang Q; Liao Z; Ding G
    Oncotarget; 2015 Feb; 6(6):3840-7. PubMed ID: 25708809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proliferation and migration mediated by Dkk-1/Wnt/beta-catenin cascade in a model of hepatocellular carcinoma cells.
    Qin X; Zhang H; Zhou X; Wang C; Zhang H; Zhang X; Ye L
    Transl Res; 2007 Nov; 150(5):281-94. PubMed ID: 17964517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of cell cycle and expression of cyclin B1 and cyclin C protein in hepatocellular carcinoma cell line HepG2 and SMMC-7721 after of silencing β-catenin gene.
    Wang B; Xunsun ; Liu JY; Yang D; Yang LL; Kong DX; Meng XW
    Hepatogastroenterology; 2012; 59(114):515-8. PubMed ID: 22024040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SOX17 antagonizes WNT/β-catenin signaling pathway in hepatocellular carcinoma.
    Jia Y; Yang Y; Liu S; Herman JG; Lu F; Guo M
    Epigenetics; 2010; 5(8):743-9. PubMed ID: 20716954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant expression and function of TCF4 in the proliferation of hepatocellular carcinoma cell line BEL-7402.
    Zhao DH; Hong JJ; Guo SY; Yang RL; Yuan J; Wen CY; Zhou KY; Li CJ
    Cell Res; 2004 Feb; 14(1):74-80. PubMed ID: 15040893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No correlation between the expression of FXR and genes involved in multidrug resistance phenotype of primary liver tumors.
    Martinez-Becerra P; Vaquero J; Romero MR; Lozano E; Anadon C; Macias RI; Serrano MA; Grañé-Boladeras N; Muñoz-Bellvis L; Alvarez L; Sangro B; Pastor-Anglada M; Marin JJ
    Mol Pharm; 2012 Jun; 9(6):1693-704. PubMed ID: 22524153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Waltonitone inhibits proliferation of hepatoma cells and tumorigenesis via FXR-miR-22-CCNA2 signaling pathway.
    Yang F; Gong J; Wang G; Chen P; Yang L; Wang Z
    Oncotarget; 2016 Nov; 7(46):75165-75175. PubMed ID: 27738335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogenic STRAP Supports Hepatocellular Carcinoma Growth by Enhancing Wnt/β-Catenin Signaling.
    Wang W; Li S; Liu P; Sideras K; van de Werken HJG; van der Heide M; Cao W; Lavrijsen M; Peppelenbosch MP; Bruno M; Pan Q; Smits R
    Mol Cancer Res; 2019 Feb; 17(2):521-531. PubMed ID: 30257989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human homolog of NOTUM, overexpressed in hepatocellular carcinoma, is regulated transcriptionally by beta-catenin/TCF.
    Torisu Y; Watanabe A; Nonaka A; Midorikawa Y; Makuuchi M; Shimamura T; Sugimura H; Niida A; Akiyama T; Iwanari H; Kodama T; Zeniya M; Aburatani H
    Cancer Sci; 2008 Jun; 99(6):1139-46. PubMed ID: 18429952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphatidylinositol 4-phosphate adaptor protein 2 accelerates the proliferation and invasion of hepatocellular carcinoma cells by enhancing Wnt/β-catenin signaling.
    Fan W; Du F; Liu X
    J Bioenerg Biomembr; 2020 Oct; 52(5):301-309. PubMed ID: 32914361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.